Neuhaus O - Search Results

1

Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy.

Ziemssen T, Kümpfel T, Schneider H, Klinkert WE, Neuhaus O, Hohlfeld R. Ziemssen T, et al. Among authors: neuhaus o. J Neurol Sci. 2005 Jun 15;233(1-2):109-12. doi: 10.1016/j.jns.2005.03.010. J Neurol Sci. 2005. PMID: 15869765

2

Epidemiology of amyotrophic lateral sclerosis in Southern Germany.

Rosenbohm A, Peter RS, Erhardt S, Lulé D, Rothenbacher D, Ludolph AC, Nagel G; ALS Registry Study Group. Rosenbohm A, et al. J Neurol. 2017 Apr;264(4):749-757. doi: 10.1007/s00415-017-8413-3. Epub 2017 Feb 20. J Neurol. 2017. PMID: 28220290

3

Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.

Rosenbohm A, Liu M, Nagel G, Peter RS, Cui B, Li X, Kassubek J, Rothenbacher D, Lulé D, Cui L, Ludolph AC; ALS Registry Swabia Study Group. Rosenbohm A, et al. J Neurol. 2018 Apr;265(4):774-782. doi: 10.1007/s00415-018-8735-9. Epub 2018 Feb 1. J Neurol. 2018. PMID: 29392461

4

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

Neuhaus O, Farina C, Yassouridis A, Wiendl H, Then Bergh F, Dose T, Wekerle H, Hohlfeld R. Neuhaus O, et al. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7452-7. doi: 10.1073/pnas.97.13.7452. Proc Natl Acad Sci U S A. 2000. PMID: 10861011 Free PMC article.

5

[Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment].

Wiendl H, Neuhaus O, Kappos L, Hohlfeld R. Wiendl H, et al. Among authors: neuhaus o. Nervenarzt. 2000 Aug;71(8):597-610. doi: 10.1007/s001150050636. Nervenarzt. 2000. PMID: 10996910 Free PMC article. Review. German.

6

Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells.

Farina C, Then Bergh F, Albrecht H, Meinl E, Yassouridis A, Neuhaus O, Hohlfeld R. Farina C, et al. Among authors: neuhaus o. Brain. 2001 Apr;124(Pt 4):705-19. doi: 10.1093/brain/124.4.705. Brain. 2001. PMID: 11287371 Clinical Trial.

7

Mechanisms of action of glatiramer acetate in multiple sclerosis.

Neuhaus O, Farina C, Wekerle H, Hohlfeld R. Neuhaus O, et al. Neurology. 2001 Mar 27;56(6):702-8. doi: 10.1212/wnl.56.6.702. Neurology. 2001. PMID: 11288751 No abstract available.

8

Risk-benefit assessment of glatiramer acetate in multiple sclerosis.

Ziemssen T, Neuhaus O, Hohlfeld R. Ziemssen T, et al. Among authors: neuhaus o. Drug Saf. 2001;24(13):979-90. doi: 10.2165/00002018-200124130-00005. Drug Saf. 2001. PMID: 11735654

9

[Treatment of multiple sclerosis with glatiramer acetate. Current aspects of mechanisms of action, pharmacokinetics, adverse effect profile and clinical studies].

Ziemssen T, Neuhaus O, Farina C, Hartung HP, Hohlfeld R. Ziemssen T, et al. Among authors: neuhaus o. Nervenarzt. 2002 Apr;73(4):321-31. doi: 10.1007/s00115-001-1257-0. Nervenarzt. 2002. PMID: 12040979 Review. German.

10

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.

Ziemssen T, Kümpfel T, Klinkert WE, Neuhaus O, Hohlfeld R. Ziemssen T, et al. Among authors: neuhaus o. Brain. 2002 Nov;125(Pt 11):2381-91. doi: 10.1093/brain/awf252. Brain. 2002. PMID: 12390966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters